The global virtual clinical trials market was valued at USD 8.75 billion in 2023, and it is projected to expand at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2030. This growth is primarily attributed to the increase in research and development (R&D) activities, the digitization of the healthcare industry, and the...